<DOC>
	<DOCNO>NCT00621387</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled trial effect 3-month treatment combination 200 mg ofloxacin twice daily 150 mg roxithromycin twice daily clinical course recent-onset reactive arthritis . Patients followed-up regular interval 6 month . The main outcome measure recovery arthritis , secondary outcome measure include swollen tender joint count , Ritchie index , joint pain , serum C-reactive protein level blood erythrocyte sedimentation rate . The study also address safety tolerability long-term antibiotic treatment . 56 patient enrolled enrollment patient complete .</brief_summary>
	<brief_title>Study Long-Term Antibiotic Treatment Reactive Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Reactive</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Roxithromycin</mesh_term>
	<criteria>1 . Diagnosis acute reactive arthritis 2 . Preceding infection confirm positive culture and/or serology , history urethritis gastroenteritis within precede 2 month 3 . Age 18 old 1 . Allergy quinolones macrolides 2 . Treatment systemic corticosteroid within 2 week 3 . Serum creatinine level elevate reference limit 4 . Alanine aminotransferase alkaline phosphatase level elevate twice reference limit 5 . Current planned pregnancy , lack contraception 6 . Known HIV positivity 7 . Blood leukocyte count less 4.0x109/l 8 . Blood platelet count less 100x109/l 9 . Lack cooperation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>reactive arthritis</keyword>
	<keyword>antibiotic</keyword>
</DOC>